What are the methodological and ethical challenges in extracting pathogen genomes from ancient human remains?

Q. What are the methodological and ethical challenges in extracting pathogen genomes from ancient human remains? (15 marks, 250-350 words)

Palaeogenomics — recovering ancient DNA (aDNA) from skeletal or mummified remains — has begun rewriting epidemic history. The 2026 Science study recovering the first smallpox (Orthopoxvirus variola) genomes of the Americas from two mummified individuals in northern Chile, dated 1492–1631 CE [1], illustrates both the payoff and the twin technical and ethical hurdles such work faces.

Methodological challenges - Degradation: aDNA survives only as short, chemically damaged fragments, demanding deep sequencing and damage-pattern authentication to separate genuine ancient reads from noise. - Low pathogen signal: viral DNA is a minute fraction against human and soil-microbe background; the Chilean variola find was accidental, emerging from a study aimed at population ancestry [1]. - Contamination by modern DNA and handling requires clean-room protocols and strict controls. - Dating and clock calibration: lineage divergence (~1296 CE) must not be conflated with the infection date (1492–1631 CE); substitution rates themselves shift — steady gene inactivation till the late 16th century, then constraint and rebound [1]. - Preservation bias: arid, cold sites like the Atacama preserve remains; tropical regions rarely yield genomes, skewing the global disease map.

Ethical challenges - Destructive sampling: bone is irreversibly consumed, conflicting with the custodial duty toward ancestral remains. - Consent and community rights: the dead cannot consent; UNDRIP Article 12 affirms Indigenous peoples' rights over ceremonial objects and repatriation of human remains, implying prior consultation with descendant communities [3]. - Sovereignty and benefit-sharing: the Nagoya Protocol's access-and-benefit-sharing norms caution against "helicopter research" that exports samples without returning gains to source nations [4]. - Stigmatisation of descendant groups linked to disease, and biosecurity risk from published sequences of an eradicated pathogen whose live stocks WHO keeps under tight control [2].

Ancient pathogen genomics converts contested colonial narratives into hard evidence, but its legitimacy rests on how the remains are treated. A community-partnered model — minimally destructive sampling, prior informed consent, data co-ownership and eventual repatriation, framed by UNDRIP and Nagoya norms — lets the discipline serve both scientific truth and historical justice.

(~320 words)

Sources: 1. The genomic identity of early smallpox in South America — Science (2026), doi:10.1126/science.aee6957 — first American variola genomes, 1492–1631 CE dating, ~1296 CE lineage divergence, accidental discovery, substitution-rate shifts 2. WHO — Smallpox (health topic) — eradication and continued regulation of variola virus stocks; biosecurity concern 3. United Nations Declaration on the Rights of Indigenous Peoples, Article 12 — Indigenous rights over human remains and repatriation 4. Nagoya Protocol on Access to Genetic Resources and Benefit-Sharing, CBD — sovereign rights over genetic resources, fair and equitable benefit-sharing